Wellington Management Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | – | Sell |
-4,813
| Closed | -$334K | – | 2231 |
|
2018
Q3 | $334K | Buy |
+4,813
| New | +$334K | ﹤0.01% | 2119 |
|
2018
Q1 | – | Sell |
-15,767
| Closed | -$842K | – | 2297 |
|
2017
Q4 | $842K | Sell |
15,767
-19,478
| -55% | -$1.04M | ﹤0.01% | 1910 |
|
2017
Q3 | $2.1M | Hold |
35,245
| – | – | ﹤0.01% | 1697 |
|
2017
Q2 | $2.78M | Buy |
35,245
+30,348
| +620% | +$2.39M | ﹤0.01% | 1606 |
|
2017
Q1 | $406K | Buy |
+4,897
| New | +$406K | ﹤0.01% | 2095 |
|
2016
Q2 | – | Sell |
-18,700
| Closed | -$757K | – | 2180 |
|
2016
Q1 | $757K | Sell |
18,700
-11,917
| -39% | -$482K | ﹤0.01% | 1862 |
|
2015
Q4 | $2.72M | Buy |
30,617
+4,367
| +17% | +$387K | ﹤0.01% | 1538 |
|
2015
Q3 | $1.94M | Buy |
26,250
+20,950
| +395% | +$1.55M | ﹤0.01% | 1633 |
|
2015
Q2 | $429K | Buy |
+5,300
| New | +$429K | ﹤0.01% | 1982 |
|